Comparative analysis of the host response to community-acquired and hospital-acquired pneumonia in critically ill patients

American Journal of Respiratory and Critical Care Medicine

Volumn 194, Issue 11, 2016, Pages 1366-1374

  Van Vught, Lonneke A ^a   Scicluna, Brendon P ^a   Wiewel, Maryse A ^a   Hoogendijk, Arie J ^a   Klouwenberg, Peter M C Klein ^a   Franitza, Marek ^b,c   Toliat, Mohammad R ^b   Nürnberg, Peter ^b,c   Cremer, Olaf L ^a   Horn, Janneke ^d   Schultz, Marcus J ^d   Bonten, Marc M J ^a   Van Der Poll, Tom ^a,e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Department of Intensive Care ^*  (Germany)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Critically Ill; Genomics; Intensive care unit; Pneumonia; Sepsis

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANTITHROMBIN; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FRACTALKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NEUTROPHIL COLLAGENASE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CELL ADHESION; CELL JUNCTION; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAPEDESIS; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL READMISSION; HUMAN; IMMUNE RESPONSE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEOMICS; PROTHROMBIN TIME; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; CLINICAL TRIAL; COMMUNITY ACQUIRED INFECTION; CRITICAL ILLNESS; CROSS INFECTION; IMMUNOLOGY; MULTICENTER STUDY; PNEUMONIA; SEVERITY OF ILLNESS INDEX;

COMMUNITY-ACQUIRED INFECTIONS; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 85002637748     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201602-0368OC     Document Type: Article

References (27)

1. World Health Organization. World Health Organization. Fact sheet No. 310; 2014 [updated 2014 May; accessed 2015 Dec. 11]. Available from: http://www.who.int/mediacentre/factsheets/fs310/en
2. Angus DC, Van Der Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369:840-851.
3. Dhainaut JF, Claessens YE, Janes J, Nelson DR. Underlying disorders and their impact on the host response to infection. Clin Infect Dis 2005;41:S481-S489.
4. Wunderink RG. Nosocomial pneumonia, including ventilator-associated pneumonia. Proc Am Thorac Soc 2005;2:440-444.
5. Deng JC, Cheng G, Newstead MW, Zeng X, Kobayashi K, Flavell RA, Standiford TJ. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J Clin Invest 2006;116:2532-2542.
6. Renckens R, Van Westerloo DJ, Roelofs JJ, Pater JM, Schultz MJ, Florquin S, Van Der Poll T. Acute phase response impairs host defense against Pseudomonas aeruginosa pneumonia in mice. Crit Care Med 2008;36:580-587.
7. Van Westerloo DJ, Schultz MJ, Bruno MJ, De Vos AF, Florquin S, Van Der Poll T. Acute pancreatitis in mice impairs bacterial clearance from the lungs, whereas concurrent pneumonia prolongs the course of pancreatitis. Crit Care Med 2004;32:1997-2001.
8. Lord JM, Midwinter MJ, Chen YF, Belli A, Brohi K, Kovacs EJ, Koenderman L, Kubes P, Lilford RJ. The systemic immune response to trauma: an overview of pathophysiology and treatment. Lancet 2014;384:1455-1465.
9. Klein Klouwenberg PM, Ong DS, Bos LD, De Beer FM, Van Hooijdonk RT, Huson MA, Straat M, Van Vught LA, Wieske L, Horn J, et al. Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients. Crit Care Med 2013;41:2373-2378.
10. Scicluna BP, Klein Klouwenberg PM, Van Vught LA, Wiewel MA, Ong DS, Zwinderman AH, Franitza M, Toliat MR, Nürnberg P, Hoogendijk AJ, et al. A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission. Am J Respir Crit Care Med 2015;192:826-835.
11. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014;311:1308-1316.
12. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-824.
13. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-R212.
14. Opal SM, Van Der Poll T. Endothelial barrier dysfunction in septic shock. J Intern Med 2015;277:277-293.
15. McNab F, Mayer-Barber K, Sher A, Wack A, O'Garra A. Type I interferons in infectious disease. Nat Rev Immunol 2015;15:87-103.
16. Chow C, Lee-Pack L, Senathiragah N, Rawji M, Chan M, Chan C. Community acquired, nursing home acquired and hospital acquired pneumonia: a five-year review of the clinical, bacteriological and radiological characteristics. Can J Infect Dis 1995;6:317-324.
17. Venditti M, Falcone M, Corrao S, Licata G, Serra P; Study Group of the Italian Society of Internal Medicine. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009;150:19-26.
18. Karhu J, Ala-Kokko TI, Ylipalosaari P, Ohtonen P, Laurila JJ, SyrjäläH. Hospital and long-term outcomes of ICU-treated severe communityand hospital-acquired, and ventilator-associated pneumonia patients. Acta Anaesthesiol Scand 2011;55:1254-1260.
19. Boots RJ, Lipman J, Bellomo R, Stephens D, Heller RF. Disease risk and mortality prediction in intensive care patients with pneumonia. Australian and New Zealand Practice in Intensive Care (ANZPIC II). Anaesth Intensive Care 2005;33:101-111.
20. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulmé R, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002;28:108-121.
21. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 2007;33:606-618.
22. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256.
23. Bloos F, Marshall JC, Dellinger RP, Vincent JL, Gutierrez G, Rivers E, Balk RA, Laterre PF, Angus DC, Reinhart K, et al. Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit Care 2011;15:R88.
24. Groeneveld AB, Hack CE. The role of the innate immune response in hospital-versus community-acquired infection in febrile medical patients. Int J Infect Dis 2008;12:660-670.
25. Palsson-McDermott EM, O'Neill LA. The Warburg effect then and now: from cancer to inflammatory diseases. BioEssays 2013;35:965-973.
26. Cheng SC, Joosten LA, Netea MG. The interplay between central metabolism and innate immune responses. Cytokine Growth Factor Rev 2014;25:707-713.
27. Vestweber D. How leukocytes cross the vascular endothelium. Nat Rev Immunol 2015;15:692-704.